Innovations & Challenges in Brain Health
PM360
NOVEMBER 12, 2024
They are difficult to diagnose early in a disease, the regulatory endpoints are often unprecedented and challenging, and many drugs struggle to get into the brain. The downside is that it also keeps most potential drug treatments from reaching the brain. Greene was the general manager of Oncology at Millennium Pharmaceuticals, Inc.,
52 
Let's personalize your content